Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents

scientific article published on June 2000

Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0168-8278(00)80102-6
P8608Fatcat IDrelease_lhgttraonvhsfmfcdjg4tiwcxq
P698PubMed publication ID10898318

P50authorJesús PrietoQ28324697
P2093author name stringSun Y
Qian C
Peng D
Barajas MA
P2860cites workPersistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectorsQ24683259
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesisQ24684374
Parvoviridae: Second ReportQ28303662
Selective extraction of polyoma DNA from infected mouse cell culturesQ29547500
Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZQ33567244
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic miceQ33733749
DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectorsQ34251868
Adeno-associated virus vectorsQ35305418
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vectorQ35872651
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinQ35943644
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virusQ36242842
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vectorQ36663364
Delivery of novel therapeutic agents in tumors: physiological barriers and strategiesQ38615180
Prospects for the use of adeno-associated virus as a vector for human gene therapyQ40643988
Treatment of hepatocellular carcinoma: too many options?Q40761519
Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cellsQ41038376
Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectorsQ42525047
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectorsQ43716886
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophiliaQ45060641
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectorsQ45299117
Adeno-associated virus-mediated gene transfer into rat carotid arteriesQ45760052
Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promotersQ45764253
Recombinant adeno-associated virus for muscle directed gene therapyQ45764433
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorQ45855552
Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposideQ45886993
The next frontier of molecular medicine: delivery of therapeutics.Q54718920
Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycinQ67254517
Hepatocellular carcinomaQ67494896
Radiation enhancement of radiolabelled antibody deposition in tumorsQ69447389
High-performance liquid chromatography determination of 4'-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene beta-D-glucopyranoside) (VP 16-213) in human plasmaQ70730673
Barriers to drug delivery in solid tumorsQ72141985
Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinomaQ73106027
Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscleQ73254110
High-performance liquid chromatography of etoposide in plasma and urineQ93575971
P433issue6
P921main subjectgenotoxicityQ1009245
P304page(s)975-985
P577publication date2000-06-01
P1433published inJournal of HepatologyQ15724402
P1476titleTransduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents
P478volume32

Reverse relations

cites work (P2860)
Q36308321Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model
Q37285005Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma
Q40023775Augmented transgene expression in transformed cells using a parvoviral hybrid vector
Q36948324Bioelectronome. Integrated approach to receptor chemistry, radicals, electrochemistry, cell signaling, and physiological effects based on electron transfer
Q34097306Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles
Q36458554Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
Q39031877Effect and mechanism of Mitomycin C combined with recombinant adeno-associated virus type II against glioma
Q35010189Effects of augmentation of liver regeneration recombinant plasmid on rat hepatic fibrosis
Q34482357Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies
Q35208038Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact
Q33970439Recombinant adenoassociated virus in cancer gene therapy
Q39122342Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.
Q34729878Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model
Q34804660Self-complementary AAV vectors; advances and applications
Q40678035Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice
Q26772315Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma
Q24655262Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
Q30442929Topoisomerase inhibition accelerates gene expression after adeno-associated virus-mediated gene transfer to the mammalian heart
Q36623130Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector